Northern Trust’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Northern Trust’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,516	Closed	-$3K	–	4739
2022 Q3	$3K	Hold	12,516	–	–	﹤0.01%	4694
2022 Q2	$5K	Hold	12,516	–	–	﹤0.01%	4727
2022 Q1	$9K	Hold	12,516	–	–	﹤0.01%	4704
2021 Q4	$20K	Buy	+12,516	New	+$37.9K	﹤0.01%	4708
2021 Q2	–	Sell	-47,633	Closed	-$403K	–	4647
2021 Q1	$403K	Buy	+47,633	New	+$498K	﹤0.01%	3884

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

Northern Trust's SCPS Position: Q4 2022 in Review

Northern Trust sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 12,516 shares — an estimated $3K sold.

Northern Trust first reported a position in SCPS in Q1 2021 and held it in 5 quarters. The position peaked at $403K in Q1 2021. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

Northern Trust reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Northern Trust sold 12,516 Scopus BioPharma Inc. Common Stock shares in Q4 2022, an estimated $3K.
Northern Trust first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Northern Trust's Scopus BioPharma Inc. Common Stock position peaked at $403K in Q1 2021.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.